Dysplasia and malignancy in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• Ulcerative colitis (UC) is recognized as a significant premalignant condition.
• The risk of colorectal cancer (CRC) in UC increases with total colonic involvement and disease duration exceeding 10 years.

Purpose of the Study:

• To evaluate the utility of periodic surveillance for colonic dysplasia in detecting early-stage, treatable colon cancer in high-risk individuals with ulcerative colitis.
• To clarify the role of screening in Crohn's disease.

Main Methods:

• Review of existing literature on ulcerative colitis, dysplasia, and colorectal cancer screening.
• Histopathological evaluation of epithelial changes indicative of neoplasia.

Main Results:

• Periodic surveillance for colonic dysplasia is beneficial for early detection of treatable colon cancer in selected high-risk UC patients.
• The histological definition of dysplasia requires expert pathological interpretation.
• While Crohn's disease carries a slightly elevated risk of gastrointestinal cancer, routine screening is not currently deemed clinically warranted.

Conclusions:

• Regular endoscopic surveillance for dysplasia is crucial for managing the increased colon cancer risk associated with long-standing, extensive ulcerative colitis.
• Accurate histological interpretation by experienced pathologists is essential for diagnosing dysplasia.
• Screening protocols for Crohn's disease patients require further investigation.